JewishStatusOpen the app

Jewish News 24 · Sep 5, 2026

Jewish News 24 — photo status

💉 NEW MODERNA mRNA FLU VACCINE AVAILABLE: Moderna’s new mRNA flu vaccine, mFlusiva, is now FDA-approved for adults 50 and older. In a large Phase 3 trial, the vaccine showed about 27% greater relative protection against confirmed influenza than a standard flu shot among adults ages 50–64. The egg-free vaccine uses mRNA technology that can be updated more quickly to match circulating strains, with common side effects including arm pain and temporary fatigue, according to ABC7.

💉 NEW MODERNA mRNA FLU VACCINE AVAILABLE: Moderna’s new mRNA flu vaccine, mFlusiva, is now FDA-approved for adults 50 and older. In a large Phase 3 trial, the vaccine showed about 27% greater relative protection against confirmed influenza than a standard flu shot among adults ages 50–64. The egg-free vaccine uses mRNA technology that can be updated more quickly to match circulating strains, with common side effects including arm pain and temporary fatigue, according to ABC7.

Watch in the app All of Jewish News 24's statuses

More from Jewish News 24